Patents by Inventor Jorge Garcia-Lara
Jorge Garcia-Lara has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 9610341Abstract: The disclosure relates to a composition comprising one, two or more immunogenic bacterial polypeptides and multivalent and monovalent vaccine compositions comprising the immunogenic bacterial polypeptides.Type: GrantFiled: April 9, 2013Date of Patent: April 4, 2017Assignee: Absynth Biologics LimitedInventors: Jorge Garcia Lara, Simon Foster
-
Publication number: 20160120969Abstract: The disclosure relates to a composition comprising two or more immunogenic staphylococcal polypeptides and a multivalent vaccine composition comprising the immunogenic staphylococcal polypeptides.Type: ApplicationFiled: January 11, 2016Publication date: May 5, 2016Inventors: Jorge Garcia Lara, Simon Foster
-
Patent number: 9233150Abstract: The disclosure relates to a composition comprising two or more immunogenic staphylococcal polypeptides and a multivalent vaccine composition comprising the immunogenic staphylococcal polypeptides.Type: GrantFiled: April 11, 2012Date of Patent: January 12, 2016Assignee: Absynth Biologics LimitedInventors: Jorge Garcia Lara, Simon Foster
-
Patent number: 9067980Abstract: The invention relates to antigenic polypeptides expressed by pathogenic microbes, vaccines comprising said polypeptides; therapeutic antibodies directed to said polypeptides and methods to manufacture said polypeptides, vaccines and antibodies.Type: GrantFiled: December 10, 2013Date of Patent: June 30, 2015Assignee: Absynth Biologics LimitedInventors: Simon J. Foster, Jorge Garcia-Lara
-
Publication number: 20150050312Abstract: The disclosure relates to a composition comprising one, two or more immunogenic bacterial polypeptides and multi-valent and monovalent vaccine compositions comprising the immunogenic bacterial polypeptides.Type: ApplicationFiled: April 9, 2013Publication date: February 19, 2015Inventors: Jorge Garcia Lara, Simon Foster
-
Publication number: 20140161835Abstract: The invention relates to an antigenic polypeptide referred to as DivIB and variants thereof, vaccines and immunogenic compositions comprising said polypeptide and the use of the vaccines and/or immunogenic compositions in the treatment and prevention of microbial infections.Type: ApplicationFiled: February 6, 2014Publication date: June 12, 2014Applicant: ABSYNTH BIOLOGICS LIMITEDInventors: Jorge GARCIA LARA, Simon FOSTER
-
Publication number: 20140099314Abstract: The invention relates to antigenic polypeptides expressed by pathogenic microbes, vaccines comprising said polypeptides; therapeutic antibodies directed to said polypeptides and methods to manufacture said polypeptides, vaccines and antibodies.Type: ApplicationFiled: December 10, 2013Publication date: April 10, 2014Applicant: ABSYNTH BIOLOGICS LIMITEDInventors: Simon J. FOSTER, Jorge GARCIA-LARA
-
Patent number: 8691242Abstract: The invention relates to an antigenic polypeptide referred to as DivlB and variants thereof, vaccines comprising said polypeptide and the use of the vaccine in protecting subjects from microbial infection.Type: GrantFiled: September 13, 2010Date of Patent: April 8, 2014Assignee: Absynth Biologics LimitedInventors: Jorge Garcia Lara, Simon Foster
-
Publication number: 20140044747Abstract: The disclosure relates to a composition comprising two or more immunogenic staphylococcal polypeptides and a multivalent vaccine composition comprising the immunogenic staphylococcal polypeptides.Type: ApplicationFiled: April 11, 2012Publication date: February 13, 2014Applicant: ABSYNTH BIOLOGICS LIMITEDInventors: Jorge Garcia Lara, Simon Foster
-
Patent number: 8632779Abstract: The invention relates to antigenic polypeptides expressed by pathogenic microbes, vaccines comprising said polypeptides; therapeutic antibodies directed to said polypeptides and methods to manufacture said polypeptides, vaccines and antibodies.Type: GrantFiled: March 14, 2012Date of Patent: January 21, 2014Assignee: Absynth Biologics LimitedInventors: Simon J. Foster, Jorge Garcia-Lara
-
Publication number: 20120195920Abstract: The invention relates to an antigenic polypeptide referred to as DivlB and variants thereof, vaccines comprising said polypeptide and the use of the vaccine in protecting subjects from microbial infection.Type: ApplicationFiled: September 13, 2010Publication date: August 2, 2012Applicant: ABSYNTH BIOLOGICS LIMITEDInventors: Jorge Garcia Lara, Simon Foster
-
Publication number: 20120171214Abstract: The invention relates to antigenic polypeptides expressed by pathogenic microbes, vaccines comprising said polypeptides; therapeutic antibodies directed to said polypeptides and methods to manufacture said polypeptides, vaccines and antibodies.Type: ApplicationFiled: March 14, 2012Publication date: July 5, 2012Applicant: ABSYNTH BIOLOGICS LIMITEDInventors: Simon J. FOSTER, Jorge GARCIA-LARA
-
Patent number: 8163288Abstract: The invention relates to antigenic polypeptides expressed by pathogenic microbes, vaccines comprising said polypeptides; therapeutic antibodies directed to said polypeptides and methods to manufacture said polypeptides, vaccines and antibodies.Type: GrantFiled: June 29, 2010Date of Patent: April 24, 2012Assignee: Absynth Biologics LimitedInventors: Simon J. Foster, Jorge Garcia-Lara
-
Publication number: 20110091465Abstract: The invention relates to antigenic polypeptides expressed by pathogenic microbes, vaccines comprising said polypeptides; therapeutic antibodies directed to said polypeptides and methods to manufacture said polypeptides, vaccines and antibodies.Type: ApplicationFiled: June 29, 2010Publication date: April 21, 2011Applicant: ABSYNTH BIOLOGICS LIMITEDInventors: Simon J. FOSTER, Jorge GARCIA-LARA
-
Patent number: 7767211Abstract: The invention relates to antigenic polypeptides expressed by pathogenic microbes, vaccines comprising said polypeptides; therapeutic antibodies directed to said polypeptides and methods to manufacture said polypeptides, vaccines and antibodies.Type: GrantFiled: March 8, 2006Date of Patent: August 3, 2010Assignee: Absynth Biologics LimtedInventors: Simon J. Foster, Jorge Garcia-Lara
-
Publication number: 20080311108Abstract: The invention relates to antigenic polypeptides expressed by pathogenic microbes, vaccines comprising said polypeptides; therapeutic antibodies directed to said polypeptides and methods to manufacture said polypeptides, vaccines and antibodies.Type: ApplicationFiled: March 8, 2006Publication date: December 18, 2008Applicant: ABSYNTH BIOLOGICS LIMITEDInventors: Simon J. Foster, Jorge Garcia-Lara